The UNC/Emory Center for Innovative Technology (iTech) across the prevention and care continuum

虽然艾滋病毒在美国的流行在许多年龄段已经趋于平稳，但从2000年到2010年，每年 青年男男性行为者(13-24岁)中新诊断的艾滋病毒感染人数超过 翻倍。2010年，在13至24岁的人群中，72%的新感染者是由YMSM引起的，占所有感染者的30% 男男性接触者中的新感染。成功地将治疗作为预防，以减少新的艾滋病毒感染人数 青年中的感染，特别是YMSM，依赖艾滋病毒检测、抗逆转录病毒治疗(两者都适用于 (治疗和预防)、坚持和抑制艾滋病毒携带者。北卡罗来纳大学/埃默里中心 创新技术(ITech)旨在通过开展创新、跨学科的 以技术为基础的青少年艾滋病毒预防和护理干预研究 以及美国(美国)的年轻人。ITech还创建了一个基础设施来共享和传播 向其他ATN项目和方案提供技术艾滋病毒干预的最佳做法 青少年。ITech的总体目标是减少艾滋病毒对青少年和青少年生活的影响 在美国的成年人，特别是YMSM，通过提供：1)作为预防那些没有艾滋病毒但处于危险中的人的治疗； 2)对那些感染但未确诊的人进行更早的识别和治疗；3)采取干预措施，解决结构性疾病 减少获得和接受预防和护理服务的决定因素；和4)治疗 采取干预措施，鼓励青年遵守与药物使用、心理健康有关的问题， 污名化和剥夺公民权。为艾滋病毒/艾滋病调查人员提供必要的资源和支助 这些目标将由iTech核心提供：1)管理(Hightow-Weidman)；2)分析 (Rosenberg/Muessig)；以及，3)技术(Sullivan/Hightow-Weidman)。为了实现我们的总体目标，我们 制定了以下具体目标：目标1：为科学领导提供专门知识和 在以技术为基础的研究方面的经验，以解决与艾滋病毒预防和治疗有关的基本问题 关怀连续体，指导我们的整体研究战略，并促进我们的iTech内部的协作和协同 并与更广泛的ATN科学界合作。目标2：支持制定和评估 针对高危人群艾滋病毒预防和护理连续体的以技术为重点的创新干预措施 或受感染的15-24岁青年。目标3：通过参与以下活动支持ATN的总体科学议程 ATN执行委员会并与其他U19获奖者合作，促进新的协同和 响应赠款申请和研究，以应对这一领域新出现的问题。目标4：发展 并培育伙伴关系，确保社区在概念化、设计、 实施，并对研究进行解释。目标5.培养、指导和培训临床医生和 研究人员将创新的艾滋病毒/艾滋病研究重点放在整个护理领域的技术创新 连续体。

While the epidemic of HIV in the US has leveled off for many age groups, from 2000-2010, the annual number of new HIV diagnoses among young men who have sex with men (YMSM) (13-24 year old) more than doubled. In 2010, YMSM accounted for 72% of new infections among people ages 13 to 24, and 30% of all new infections among MSM. The success of treatment as prevention in reducing the number of new HIV infections among youth, and particularly YMSM, relies on HIV testing, antiretroviral treatment (both for treatment and prevention), adherence and viral suppression among those with HIV. The UNC/Emory Center for Innovative Technology (iTech) aims to impact the HIV epidemic by conducting innovative, interdisciplinary research on technology-based interventions across the HIV prevention and care continuum for adolescents and young adults in the United States (US). The iTech also creates an infrastructure to share and disseminate best practices in technology-delivered HIV interventions to other ATN projects and programs serving adolescents. The iTech overall goals seek to decrease the impact of HIV on the lives of adolescents and young adults in the US, particularly YMSM, by providing: 1) treatment as prevention for those without HIV but at risk; 2) earlier identification and treatment for those infected but undiagnosed; 3) interventions to address structural determinants that decrease access to and uptake of prevention and care services; and 4) treatment interventions to encourage adherence for youth dealing with substance use, mental health related issues, stigmatization and disenfranchisement. The necessary resources and support for HIV/AIDS investigators addressing these goals will be provided by the iTech Cores: 1) Management (Hightow-Weidman); 2) Analytic (Rosenberg/Muessig); and, 3) Technology (Sullivan/Hightow-Weidman). To accomplish our Overall Goals we have developed the following Specific Aims: Aim 1: To provide scientific leadership with expertise and experience in technology-based research to address fundamental questions related to the HIV prevention and care continuum, guide our overall research strategy and foster collaboration and synergy both within our iTech and with the broader ATN scientific community. Aim 2: To support the development and assessment of innovative technology-focused interventions addressing the HIV prevention and care continuum for at-risk or infected youth aged 15-24 years. Aim 3: To support the overall ATN scientific agenda by participating on the ATN Executive Committee and collaborating with other U19 awardees stimulating new synergistic and responsive grants applications and research to respond to emerging issues in this field. Aim 4: To develop and nurture partnerships that will ensure community input at all stages of conceptualization, design, implementation, and interpretation of the research. Aim 5. To develop, mentor and train clinicians and researchers to stimulate innovative HIV/AIDS research focused on technological innovation across the care continuum.